Cargando…
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironm...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091076/ https://www.ncbi.nlm.nih.gov/pubmed/36999632 http://dx.doi.org/10.3892/or.2023.8535 |
_version_ | 1785023081469706240 |
---|---|
author | Higashiguchi, Masaya Murakami, Hirotomo Akita, Hirofumi Kobayashi, Shogo Takahama, Shokichi Iwagami, Yoshifumi Yamada, Daisaku Tomimaru, Yoshito Noda, Takehiro Gotoh, Kunihito Doki, Yuichiro Yamamoto, Takuya Eguchi, Hidetoshi |
author_facet | Higashiguchi, Masaya Murakami, Hirotomo Akita, Hirofumi Kobayashi, Shogo Takahama, Shokichi Iwagami, Yoshifumi Yamada, Daisaku Tomimaru, Yoshito Noda, Takehiro Gotoh, Kunihito Doki, Yuichiro Yamamoto, Takuya Eguchi, Hidetoshi |
author_sort | Higashiguchi, Masaya |
collection | PubMed |
description | Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironment by inducing a senescence-associated secretory phenotype (SASP). In the present study, the effects of individual differences in CAFs on PC malignancy were investigated with a focus on cellular senescence. First, primary cultures of CAFs from 8 PC patients were generated and co-cultured with PC cell lines. This co-culture assay showed that differences in CAFs induce differences in PC cell proliferation. It was further investigated which clinical factors affected the malignant potential of CAF and it was found that the difference of malignant potential of each CAF was marginally related to the age of original patients. Next, to verify the senescence of CAFs really affected the malignant potential of CAF, PCR array analysis of each CAF sample was performed and it was revealed that expression of genes about cellular senescence and SASP such as tumor protein p53, nuclear factor kappa B subunit 1, and IL6, are related to the malignant potential of CAFs impacting on PC proliferation. Finally, to elucidate the effect of p53-mediated cellular senescence of CAFs on malignant potential of PC, it was examined whether CAFs with the treatment of p53 inhibitor affected PC cell proliferation in co-culture assays. The treatment of CAFs with p53 inhibitor significantly suppressed PC cell proliferation. In addition, a comparison of the concentration of IL-6, a SASP cytokine, in the co-culture supernatant showed a significant decrease in the sample after p53 inhibitor treatment. In conclusion, the present results suggested that proliferation potential of PC may be related to p53-mediated cellular senescence and SASP of CAFs. |
format | Online Article Text |
id | pubmed-10091076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-100910762023-04-13 The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer Higashiguchi, Masaya Murakami, Hirotomo Akita, Hirofumi Kobayashi, Shogo Takahama, Shokichi Iwagami, Yoshifumi Yamada, Daisaku Tomimaru, Yoshito Noda, Takehiro Gotoh, Kunihito Doki, Yuichiro Yamamoto, Takuya Eguchi, Hidetoshi Oncol Rep Articles Cancer-associated fibroblasts (CAFs) are implicated in the strong malignancy of pancreatic cancer (PC). Various CAF subtypes have different functions, and their heterogeneity likely influence the malignancy of PC. Meanwhile, it is known that senescent cells can create a tumor-promoting microenvironment by inducing a senescence-associated secretory phenotype (SASP). In the present study, the effects of individual differences in CAFs on PC malignancy were investigated with a focus on cellular senescence. First, primary cultures of CAFs from 8 PC patients were generated and co-cultured with PC cell lines. This co-culture assay showed that differences in CAFs induce differences in PC cell proliferation. It was further investigated which clinical factors affected the malignant potential of CAF and it was found that the difference of malignant potential of each CAF was marginally related to the age of original patients. Next, to verify the senescence of CAFs really affected the malignant potential of CAF, PCR array analysis of each CAF sample was performed and it was revealed that expression of genes about cellular senescence and SASP such as tumor protein p53, nuclear factor kappa B subunit 1, and IL6, are related to the malignant potential of CAFs impacting on PC proliferation. Finally, to elucidate the effect of p53-mediated cellular senescence of CAFs on malignant potential of PC, it was examined whether CAFs with the treatment of p53 inhibitor affected PC cell proliferation in co-culture assays. The treatment of CAFs with p53 inhibitor significantly suppressed PC cell proliferation. In addition, a comparison of the concentration of IL-6, a SASP cytokine, in the co-culture supernatant showed a significant decrease in the sample after p53 inhibitor treatment. In conclusion, the present results suggested that proliferation potential of PC may be related to p53-mediated cellular senescence and SASP of CAFs. D.A. Spandidos 2023-03-27 /pmc/articles/PMC10091076/ /pubmed/36999632 http://dx.doi.org/10.3892/or.2023.8535 Text en Copyright: © Higashiguchi et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Higashiguchi, Masaya Murakami, Hirotomo Akita, Hirofumi Kobayashi, Shogo Takahama, Shokichi Iwagami, Yoshifumi Yamada, Daisaku Tomimaru, Yoshito Noda, Takehiro Gotoh, Kunihito Doki, Yuichiro Yamamoto, Takuya Eguchi, Hidetoshi The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title | The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title_full | The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title_fullStr | The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title_full_unstemmed | The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title_short | The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
title_sort | impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091076/ https://www.ncbi.nlm.nih.gov/pubmed/36999632 http://dx.doi.org/10.3892/or.2023.8535 |
work_keys_str_mv | AT higashiguchimasaya theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT murakamihirotomo theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT akitahirofumi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT kobayashishogo theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT takahamashokichi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT iwagamiyoshifumi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT yamadadaisaku theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT tomimaruyoshito theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT nodatakehiro theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT gotohkunihito theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT dokiyuichiro theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT yamamototakuya theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT eguchihidetoshi theimpactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT higashiguchimasaya impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT murakamihirotomo impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT akitahirofumi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT kobayashishogo impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT takahamashokichi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT iwagamiyoshifumi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT yamadadaisaku impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT tomimaruyoshito impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT nodatakehiro impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT gotohkunihito impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT dokiyuichiro impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT yamamototakuya impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer AT eguchihidetoshi impactofcellularsenescenceandsenescenceassociatedsecretoryphenotypeincancerassociatedfibroblastsonthemalignancyofpancreaticcancer |